Gilead Sciences Inc (XTER:GIS)
€ 114.1 -0.76 (-0.66%) Market Cap: 143.26 Bil Enterprise Value: 155.94 Bil PE Ratio: 17.90 PB Ratio: 6.94 GF Score: 82/100

Gilead Sciences Inc at Bernstein Strategic Decisions Conference Transcript

May 28, 2026 / 03:00PM GMT
Release Date Price: €115.04 (-0.96%)
Courtney Breen
Sanford C Bernstein & Co LLC - Equity Analyst

Thank you so much for all being here today.

I am thrilled to be on the stage here with Dan O'Day, the Chairman and Chief Executive Officer of Gilead Sciences.

This is a company we follow a lot. We spend a lot of time thinking about.

And we're very excited to give you an opportunity to tell the Gilead story to a broad set of investors. Perhaps I'll start with letting you just give some opening remarks to contextualize Gilead, the story, where we're at today, and what's on the horizon. And then I've got some Q&A that I would love to go through.

For all of those in the room as well, please do see that the QR code dotted around in multiple places, I think on your lanyards as well.

Please feel free to use this to add questions to the pigeonhole.

And I can then integrate them into the conversation. I really want to make sure it's as relevant as possible for everyone in the room and we get through the questions that are most important to you all. So with that, Dan would love to get

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot